Skip to main content
BioMaxima S.A. logo

BioMaxima S.A. — Investor Relations & Filings

Ticker · BMX ISIN · PLBIOMX00015 LEI · 2594007GAALFMXP4YB89 WAR Manufacturing
Open in API
Filings indexed 617 across all filing types
Latest filing 2023-05-18 AGM Information
Country PL Poland
Listing WAR BMX

About BioMaxima S.A.

https://www.biomaxima.com/

BioMaxima S.A. is a manufacturer specializing in in-vitro diagnostics. The company's primary activities include the development and production of a wide range of products for laboratory diagnostics, with a focus on clinical microbiology. Key product categories include microbiological media, various diagnostic reagents, and specialized laboratory equipment. In addition to its manufacturing operations, BioMaxima also serves as a distributor for products from other global diagnostics firms. The company is actively involved in product innovation, including the development of Minimum Inhibitory Concentration (MIC) tests for antibiotic susceptibility testing.

Recent filings

Filing Released Lang Actions
Ogłoszenie o zwołaniu wraz z projektami uchwał
AGM Information Classification · 100% confidence The document is titled "Ogłoszenie o zwołaniu Zwyczajnego Walnego Zgromadzenia Akcjonariuszy BioMaxima Spółka Akcyjna" (Announcement of the convening of the Annual General Meeting of Shareholders of BioMaxima S.A.). It details the date (June 14, 2023), location, and the full agenda (Porządek obrad) for the meeting. The agenda includes items typical for an AGM, such as approving management and supervisory board reports for 2022, approving financial statements for 2022, and granting discharge (absolutorium) to management board members for 2022. It also outlines shareholder rights regarding proposals and proxy voting. Since the document is the official notice and agenda for the Annual General Meeting (Zwyczajne Walne Zgromadzenie), the correct classification is AGM Information (AGM-R).
2023-05-18 Polish
Ogłoszenie o zwołaniu ZWZ Biomaxima S.A. wraz z projektami uchwał - Content (PL)
AGM Information Classification · 98% confidence The document text explicitly states that the Management Board ('Zarząd') of BioMaxima S.A. is announcing ('przekazuje do publicznej wiadomości') the convening of the Ordinary General Meeting ('Zwyczajnego Walnego Zgromadzenia') along with draft resolutions ('projektami uchwał'). This content directly relates to the materials prepared for and announced regarding the Annual General Meeting (AGM). Therefore, the appropriate classification is AGM Information (AGM-R). The document is very short, but the content is specific to the AGM event itself, not just an announcement that a report is available.
2023-05-18 Polish
Oświadczenie Rady Nadzorczej ws. Komitetu Audytu
Governance Information Classification · 98% confidence The document is titled "Oświadczenie Rady Nadzorczej BioMaxima S.A. dotyczące funkcjonowania Komitetu Audytu w roku obrotowym 2022" (Statement of the Supervisory Board of BioMaxima S.A. regarding the functioning of the Audit Committee in the 2022 financial year). This content directly relates to the internal rules, board structure, and governance practices of the company, specifically focusing on the Audit Committee's operations and compliance for the year 2022. This aligns perfectly with the definition of Governance Information (CGR). It is not an Annual Report (10-K), an Audit Report (AR), or an Earnings Release (ER). It is a specific governance statement.
2023-04-28 Polish
Podpis pod oceną
Regulatory Filings Classification · 95% confidence The document text consists almost entirely of XML structures related to digital signatures, specifically referencing 'Signature', 'SignedInfo', 'DigestValue', 'X509Certificate', and 'SigningTime'. The presence of a reference URI pointing to a file named 'BMX_RN_OCE_2022-12-31_pl.xhtml' suggests this is a wrapper or metadata file accompanying a primary document. Furthermore, the content does not contain typical financial reporting language (like 'revenue', 'net income', 'balance sheet') nor does it resemble a standard regulatory filing format (like 10-K or IR). The structure strongly indicates a digitally signed regulatory submission or announcement. Given the fallback options, and the fact that this is a signed artifact likely accompanying a primary filing, the most appropriate general category for an unidentifiable, signed regulatory document is 'Regulatory Filings' (RNS), as it serves as a catch-all for miscellaneous filings that don't fit specific categories like ER, 10-K, or DIV, especially when the core content is technical metadata.
2023-04-28 Polish
Ocena Rady Nadzorczej
Audit Report / Information Classification · 98% confidence The document is titled 'Ocena Rady Nadzorczej BioMaxima S.A. Dotycząca sprawozdania z działalności Grupy Kapitałowej i skonsolidowanego sprawozdania finansowego za okres zakończony 31 grudnia 2022 roku' (Supervisory Board Assessment regarding the activity report of the Capital Group and the consolidated financial statement for the period ended December 31, 2022). This document details the Supervisory Board's review and approval of the annual financial statements and management report, referencing accounting standards and the audit conducted by Grant Thornton. This content strongly aligns with the scope of an Audit Report or Information (AR), which covers assessments related to financial statements, especially when it is a standalone assessment document rather than the full 10-K filing itself. Given the focus on the audit review and assessment of the annual financial statements, AR is the most appropriate classification. FY 2022
2023-04-28 Polish
Podpis pod opinią
Regulatory Filings Classification · 95% confidence The provided document text consists almost entirely of XML digital signature blocks (Signatures, SignedInfo, SignatureValue, KeyInfo, X509Certificate, etc.). This structure is typical for digitally signed regulatory filings or official documents, often found within XBRL or XML-based submissions to regulatory bodies. The presence of a certificate issued to 'Krajowa Izba Rozliczeniowa S.A.' (a Polish entity) and references to 'Biomaxima_SA_2022_BSF_MSSF_SzB_PL_emitent.xhtml' suggests a formal, signed financial document from a Polish issuer. However, the text itself is not the content of a report (like 10-K, IR, or ER); it is metadata confirming the document's authenticity and integrity. Since the content is just the signature block and the original document referenced is an XHTML file (likely the actual report), this structure strongly suggests this is an attachment or wrapper file accompanying a primary filing, or perhaps a specific type of regulatory confirmation. Given the options, this structure does not fit well into specific content categories like 10-K, ER, or IR. It is a generic regulatory artifact. The most appropriate fallback category for a document that is purely a regulatory signature/validation wrapper, and doesn't clearly announce another report (RPA), is the general 'Regulatory Filings' category (RNS). The document length (5343 chars) is substantial enough that it might contain more context if fully provided, but based solely on the provided XML signature structure, RNS is the best fit as a catch-all for formal, non-content-specific regulatory artifacts.
2023-04-28 Polish

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.